Table 2 MicroRNAs in the effect of cancer-associated fibroblasts on cancer cells
Cancer type | miRNA | Expression | Function | Upstream signaling | Target molecules or pathways | References |
|---|---|---|---|---|---|---|
miRNA dysregulation | ||||||
Breast cancer | miR-141 | ↓ | Proliferation | TGF-β1/DNMT3B | TCF12/ CXCL12/ c-Myc/CyclinD1 | [109] |
Breast cancer | miR-29b | ↓ | Proliferation, Chemoresistance | – | CCL11, CXCL14, p38/STAT1 | [111] |
Breast cancer | miR-200b, c | ↓ | Proliferation, EMT, Invasion | – | IKKβ/NF-κB/PAI-1 | [113] |
Breast cancer | miR-200s | ↓ | Metastasis | – | Fli-1, TCF12 | [138] |
Cholangiocarcinoma | miR-15a | ↓ | Migration | – | PAI-2 | [140] |
Colorectal cancer | miR-192, miR-17, miR-200c | ↓ | Invasion | – | ECM Associated Genes | [139] |
Colorectal cancer | miR-21 | ↑ | Proliferation, Invasion, Chemoresistance | – | RECK, MMP2 | [83] |
Endometrial cancer | miR-148a | ↓ | Proliferation, Migration | – | WNT10B, Wnt/β-catenin | [141] |
Esophageal cancer | miR-27a/b | ↑ | Chemoresistance | – | TGF-β | [156] |
Gastric cancer | miR-214 | ↓ | EMT, Migration | – | FGF9 | [143] |
Gastric cancer | miR-149 | ↓ | Proliferation, EMT | COX-2/PGE2, DNA Hypermethylation | IL-6 | [87] |
Head and Neck cancer | miR-7 | ↑ | Proliferation, Migration | - | RASSF2, PAR-4 | [114] |
Lung cancer | miR-101 | ↓ | Proliferation | - | CXCL12 | [82] |
Lung cancer | miR-1 | ↓ | Proliferation, Chemoresistance | - | SDF-1, CXCR4, NF-κB, Bcl-xL | [155] |
Oral carcinoma | miR-124 | ↓ | Proliferation, Migration | DNA Hypermethylation | CCL2, IL-8 | [110] |
Pancreatic cancer | miR-21 | ↑ | Chemoresistance | – | Desmoplasia | [154] |
Prostate cancer | miR-15, miR-16 | ↓ | Proliferation, Migration | – | FGF-2, FGFR1 | [112] |
Prostate cancer | miR-210 | ↑ | Angiogenesis | Hypoxia | HUVECs | [105] |
Exosomal miRNA | ||||||
Breast cancer | miR-4516 | ↓ | Proliferation | – | FOSL1 | [115] |
Breast cancer | miR-205 | ↓ | Angiogenesis | – | YAP1/ IL-11, IL-15/ STAT3 | [135] |
Breast cancer | miR-181d-5p | ↑ | Proliferation, EMT | – | CDX2/HOXA5 | [144] |
Breast cancer | miR-16, miR-148a | ↑ | Metastasis | FAK | – | [148] |
Breast cancer | miR-3613-3p | ↑ | Proliferation, Metastasis | – | SOCS2 | [149] |
Colorectal cancer | miR-21 | ↑ | Metastasis | – | – | [151] |
Colorectal cancer | miR-92a-3p | ↑ | EMT, Metastasis, Chemoresistance | – | FBXW7 and MOAP1/Wnt/β-catenin | [122] |
Endometrial cancer | miR-148b | ↓ | EMT, Metastasis | – | DNMT1 | [145] |
Gastric cancer | miR-139 | ↓ | Proliferation, Metastasis | – | MMP11 | [118] |
Gastric cancer | miR-522 | ↑ | Metabolic Reprogramming, Chemoresistance | USP7/hnRNPA1 | ALOX15, lipid-ROS | [127] |
Head and neck cancer | miR-3188 | ↓ | Proliferation | – | BCL2 | [116] |
Head and neck cancer | miR-196a | ↑ | Proliferation, Chemoresistance | hnRNPA1 | CDKN1B, ING5 | [157] |
Hepatocellular carcinoma | miR-320a | ↓ | Proliferation, EMT, Metastasis | – | PBX3/ERK1/2/CDK2 | [117] |
Lung cancer | miR-210 | ↑ | Angiogenesis | – | JAK2/STAT3 | [134] |
Lung cancer | miR-210 | ↑ | EMT, Migration | – | UPF1, PTEN/PI3K/AKT | [146] |
Melanoma | miR-155 | ↑ | Angiogenesis | – | SOCS1/JAK2/STAT3 | [133] |
Oral cancer | miR-34a-5p | ↓ | Proliferation, EMT, Metastasis | – | AXL, AKT/GSK-3β/β-catenin/Snail | [147] |
Osteosarcoma | miR-1228 | ↑ | Migration | – | SCAI | [150] |
Ovarian cancer | miR-21 | ↑ | Invasion, Chemoresistance | – | APAF1 | [158] |
Ovarian cancer | miR-98-5p | ↑ | Chemoresistance | – | CDKN1A | [159] |
Pancreatic cancer | miR-146a | ↑ | Proliferation, Chemoresistance | Gemcitabine | – | [119] |
Pancreatic cancer | miR-106b | ↑ | Chemoresistance | – | TP53INP1 | [160] |